Skip to content

Morton's Neuroma: Manipulation Versus Steroid Injection

Manipulation Versus Steroid Injection in the Treatment of Morton's Neuroma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05707572
Enrollment
62
Registered
2023-02-01
Start date
2014-09-30
Completion date
2019-09-30
Last updated
2023-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morton Neuroma

Keywords

manipulation, plantar digital neuritis, morton's neuroma, nerve entrapment, foot

Brief summary

This study compares manipulative therapy to steroid injection in the treatment of Morton's Neuroma.

Detailed description

The aim of this study is to establish whether manipulative therapy is an effective treatment for Morton's neuroma, a nerve entrapment in the foot. Steroid injection is the current gold standard conservative treatment for this condition. Therefore, a subject group shall be compared to a steroid injection intervention group. Outcomes will be compared using visual analogue pain scales -VAS, Foot Function Index questionnaires and algometric pressure threshold testing. An improvement in the manipulation group VAS of 20mm above the injection group shall be considered as the minimum worthwhile change as this has been identified as the minimum clinically important difference in pain between treatment groups in visual analogue pain scales.

Interventions

DRUGmethylprednisolone

a single injection of 1 mL methylprednisolone \[40 mg\] and 1 mL 2% lignocaine

The lesser MTPJs of the affected foot will be manually manipulated using a high velocity, low amplitude thrust technique.

Sponsors

Queen Margaret University
CollaboratorOTHER
Dundee Podiatry Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of morton's neuroma * over 18 years of age * presenting VAS score \> 30mm

Exclusion criteria

* diabetes, * rheumatoid arthritis * fibromyalgia. * Those currently taking Statins or analgesics * previous neuroma surgery

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue pain scalepre treatment at each clinic visit and then 3,6,9 and 12 monthsMeasuring changes in self reported pain over time. 100mm scale with anchored prompts of no pain at 0mm and worst pain ever at 100mm

Secondary

MeasureTime frameDescription
Algometric pressure threshold meterpre treatment at each clinic visit and then 3,6,9 and 12 monthsMeasuring changes in pressure tolerance over time. A meter which reads how much change in pressure a joint can withstand before it registers discomfort

Other

MeasureTime frameDescription
Foot function index questionnairepre treatment at each clinic visit and then 3,6,9 and 12 monthsA questionnaire to establish subjects level of function, pain and mobility changes over time
Manchester Oxford Foot Pain Questionnairepre treatment at each clinic visit and then 3,6,9 and 12 monthsPatient reported outcome measurement tool to measure changes in foot pain over time
Short Form 36 pain and disability Questionnairepre treatment at each clinic visit and then 3,6,9 and 12 monthsA quality of life questionnaire

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026